RRM2 and neoplasm: We did not observe any significant difference in RRM1 or its activator and binding partner RRM2 in the MPNST cell lines as compared to HSC1 (Fig. S5A); however, these genes were both significantly upregulated in MPNST patient tumor samples as compared to benign neurofibromas (Fig. 4E).